445 related articles for article (PubMed ID: 36194337)
1. Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study.
Chen J; Dan L; Tu X; Sun Y; Deng M; Chen X; Hesketh T; Li R; Wang X; Li X
Hepatol Int; 2023 Feb; 17(1):202-214. PubMed ID: 36194337
[TBL] [Abstract][Full Text] [Related]
2. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank.
He MM; Fang Z; Hang D; Wang F; Polychronidis G; Wang L; Lo CH; Wang K; Zhong R; Knudsen MD; Smith SG; Xu RH; Song M
Int J Cancer; 2021 Apr; 148(8):1867-1878. PubMed ID: 33091956
[TBL] [Abstract][Full Text] [Related]
3. Circulating liver function markers and the risk of COPD in the UK Biobank.
Du W; Guan H; Wan X; Zhu Z; Yu H; Luo P; Chen L; Su J; Lu Y; Hang D; Tao R; Wu M; Zhou J; Fan X
Front Endocrinol (Lausanne); 2023; 14():1121900. PubMed ID: 37033218
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
[TBL] [Abstract][Full Text] [Related]
5. Higher dietary fibre intake is associated with lower risk of inflammatory bowel disease: prospective cohort study.
Deng M; Dan L; Ye S; Chen X; Fu T; Wang X; Chen J
Aliment Pharmacol Ther; 2023 Sep; 58(5):516-525. PubMed ID: 37464899
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver degree and long-term risk of incident inflammatory bowel disease: A large-scale prospective cohort study.
Zhang Q; Liu S; Wu J; Zhu S; Wu Y; Wu S; Zhang S
Chin Med J (Engl); 2023 Nov; ():. PubMed ID: 37962217
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease.
Moon JH; Kim W; Koo BK; Cho NH;
Gut Liver; 2022 May; 16(3):433-442. PubMed ID: 34635626
[TBL] [Abstract][Full Text] [Related]
8. Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Capela TL; Silva VM; Freitas M; Arieira C; Gonçalves TC; de Castro FD; Magalhães J; Cotter J
BMC Gastroenterol; 2023 Dec; 23(1):437. PubMed ID: 38093213
[TBL] [Abstract][Full Text] [Related]
9. Association of Stroke With Metabolic Dysfunction-Associated Fatty Liver Disease With and Without CKD.
Li Y; Wu S; Gao J; Zhang Y; Zuo Y; Tian X; Chen S; Xing A; Wang A; He Y
Am J Kidney Dis; 2024 Apr; 83(4):477-488. PubMed ID: 37838141
[TBL] [Abstract][Full Text] [Related]
10. Intake of Ultra-processed Foods Is Associated with an Increased Risk of Crohn's Disease: A Cross-sectional and Prospective Analysis of 187 154 Participants in the UK Biobank.
Chen J; Wellens J; Kalla R; Fu T; Deng M; Zhang H; Yuan S; Wang X; Theodoratou E; Li X; Satsangi J
J Crohns Colitis; 2023 Apr; 17(4):535-552. PubMed ID: 36305857
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Dysfunction-Associated Fatty Liver Disease in Taiwanese Patients with Inflammatory Bowel Disease: A Study in Patients with Clinical Remission.
Hsiao SW; Chen TC; Su PY; Yang CT; Huang SP; Chen YY; Yen HH
Diagnostics (Basel); 2023 Oct; 13(20):. PubMed ID: 37892089
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease without overlapping metabolic-associated fatty liver disease and the risk of incident type 2 diabetes.
Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
Liver Int; 2023 Nov; 43(11):2445-2454. PubMed ID: 37387519
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Khalili H; Konijeti GG; Higuchi LM; de Silva P; Korzenik JR; Fuchs CS; Willett WC; Richter JM; Chan AT
Gastroenterology; 2013 Nov; 145(5):970-7. PubMed ID: 23912083
[TBL] [Abstract][Full Text] [Related]
14. Microscopic Colitis and Risk of Inflammatory Bowel Disease in a Nationwide Cohort Study.
Khalili H; Burke KE; Roelstraete B; Sachs MC; Olén O; Ludvigsson JF
Gastroenterology; 2020 May; 158(6):1574-1583.e2. PubMed ID: 31926169
[TBL] [Abstract][Full Text] [Related]
15. Sugar-sweetened beverages, artificially sweetened beverages and natural juices and risk of inflammatory bowel disease: a cohort study of 121,490 participants.
Fu T; Chen H; Chen X; Sun Y; Xie Y; Deng M; Hesketh T; Wang X; Chen J
Aliment Pharmacol Ther; 2022 Sep; 56(6):1018-1029. PubMed ID: 35848057
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study Among Half a Million Adults in UK Biobank.
Wu S; Xie S; Yuan C; Yang Z; Liu S; Zhang Q; Sun F; Wu J; Zhan S; Zhu S; Zhang S
Inflamm Bowel Dis; 2023 Mar; 29(3):384-395. PubMed ID: 35639937
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
[TBL] [Abstract][Full Text] [Related]
18. Prospective association of liver function biomarkers with development of hepatobiliary cancers.
Stepien M; Fedirko V; Duarte-Salles T; Ferrari P; Freisling H; Trepo E; Trichopoulou A; Bamia C; Weiderpass E; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Fagherazzi G; Racine A; Kühn T; Kaaks R; Aleksandrova K; Boeing H; Lagiou P; Benetou V; Trichopoulos D; Palli D; Grioni S; Tumino R; Naccarati A; Panico S; Bueno-de-Mesquita HB; Peeters PH; Lund E; Quirós JR; Nápoles OC; Sánchez MJ; Dorronsoro M; Huerta JM; Ardanaz E; Ohlsson B; Sjöberg K; Werner M; Nystrom H; Khaw KT; Key TJ; Gunter M; Cross A; Riboli E; Romieu I; Jenab M
Cancer Epidemiol; 2016 Feb; 40():179-87. PubMed ID: 26773278
[TBL] [Abstract][Full Text] [Related]
19. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
20. NAFLD and MAFLD as emerging causes of HCC: A populational study.
Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
